Latest market price
152.76
-5.35-3.38%
News
Down 3.4% — Two Pills, One Target: Analyst Bets on Pharvaris as Clinical Risks Fade (benzinga.com).
Medium confidence
TA
Loading chart...
Snapshot
| Index | S&P 500 | P/E | 15.86 | EPS (ttm) | 9.63 | Insider Own | 0.50% | Shs Outstand | 454.30M | Perf Week | -0.97% |
| Market Cap | 69.40B | Forward P/E | 15.85 | EPS next Y | 9.64 | Insider Trans | -5.90% | Shs Float | 452.78M | Perf Month | -2.17% |
| Enterprise Value | 82.68B | PEG | 4.47 | EPS next Q | 2.08 | Inst Own | 64.51% | Short Float | 3.81% | Perf Quarter | 8.85% |
| Income | 4.39B | P/S | 0.64 | EPS this Y | 39.64% | Inst Trans | 0.00% | Short Ratio | 4.33 | Perf Half Y | 18.18% |
| Sales | 107.70B | P/B | 3.89 | EPS next Y | -5.48% | ROA | 7.17% | Short Interest | 17.26M | Perf YTD | 56.28% |
| Book/sh | 39.28 | P/C | 12.83 | EPS next 5Y | 3.55% | ROE | 26.66% | 52W High | 170.76 -10.54% | Perf Year | 62.48% |
| Cash/sh | 11.91 | P/FCF | 15.24 | EPS past 3/5Y | 10.78% -1.21% | ROIC | 11.35% | 52W Low | 83.44 83.08% | Perf 3Y | 38.61% |
| Dividend Est. | 4.64 (3.04%) | EV/EBITDA | 8.93 | Sales past 3/5Y | -1.34% 2.29% | Gross Margin | 29.30% | Volatility | 2.87% 2.57% | Perf 5Y | -37.83% |
| Dividend TTM | 4.58 (3.00%) | EV/Sales | 0.77 | EPS Y/Y TTM | 8.69% | Oper. Margin | 5.59% | ATR (14) | 4.19 | Perf 10Y | 125.01% |
| Dividend Ex-Date | Nov 10, 2026 | Quick Ratio | 0.36 | Sales Y/Y TTM | 1.07% | Profit Margin | 4.08% | RSI (14) | 46.08 | Recom | 2.60 |
| Dividend Gr. 3/5Y | 4.51% 11.02% | Current Ratio | 0.99 | EPS Q/Q | 100.49% | SMA20 | -1.23% | Beta | 0.92 | Target Price | 166.95 |
| Payout | 47.09% | Debt/Eq | 1.23 | Sales Q/Q | 5.27% | SMA50 | -3.08% | Rel Volume | 0.79 | Prev Close | 158.11 |
| Employees | 415,000 | LT Debt/Eq | 1.10 | Earnings | Nov 18 | SMA200 | 14.91% | Avg Volume | 4.04M | Price | 152.76 |
| IPO Date | Oct 18, 1967 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 75.21% 1.56% | Net Debt/EBITDA | 1.44 | Volume | 3,195,528 | Change | -3.38% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-13-26 | Reiterated | Evercore ISI Group | In Line | $170 → $165 |
| Sep-30-26 | Upgrade | HSBC | Hold → Buy | $190 |
| Aug-20-26 | Reiterated | Deutsche Bank | Hold | $140 → $150 |
| Aug-20-26 | Reiterated | Roth Capital | Neutral | $114 → $142 |
| Aug-20-26 | Reiterated | Robert W. Baird | $150 → $170 | |
| Aug-20-26 | Reiterated | Gordon Haskett Capital Corporation | $180 → $200 | |
| Aug-20-26 | Reiterated | Bernstein | Market Perform | $135 → $154 |
| Aug-20-26 | Reiterated | Mizuho Securities | Neutral | $122 → $150 |
| Aug-20-26 | Reiterated | Guggenheim | Buy | $150 → $175 |
| Aug-20-26 | Reiterated | RBC Capital | Outperform | $166 → $178 |
Latest News· Times ET
Oct-23-26
Oct-23-2605:05PM
02:06PM
11:03AM
07:45AM
OpenAI Just Cut Its Valuation Target by $150 Billion247wallst.com
02:58AM
Oct-22-26
Oct-22-2610:35AM
08:50AM
08:00AM
08:00AM
06:01AM
05:27AM
03:47AM
Oct-21-26
Company
Target Corp. engages in the operation and ownership of general merchandise stores. It offers food and general merchandise, clothing and household goods, electronics, and toys. Its brands include A New Day, All in Motion, Art Class, Auden, AVA & VIV, Boots and Barkley, Brightroom, Bullseye's Playground, Casaluna, Cat & Jack, Cloud Island, Colsie, dealworthy, Embark, Everspring, Favorite Day, Figmint, Future Collective, Gigglescape, Good & Gather, Goodfellow & Co, Hearth & Hand with Magnolia, Heyday, Hyde & EEK! Boutique, JoyLab, Kindfull, Kona Sol, Made By Design, Market Pantry, Mondo Llama, More Than Magic, Opalhouse, Open Story, Original Use, Pillowfort, Project 62, Room Essentials, Shade & Shore, Smartly, Smith & Hawken, Sonia Kashuk, Spritz, Sun Squad, Threshold, Universal Thread, up&up, Wild Fable, Wondershop, Xhilaration, California Roots, Casa Cantina, The Collection, Headliner, Jingle & Mingle, Rosé Bae, Photograph, SunPop, and Wine Cube. The company was founded by George Draper Dayton in 1902 and is headquartered in Minneapolis, MN.
Ownership
Total institutional ownership64.51%
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 1/31/2026 | FY 2024 2/1/2025 | FY 2023 2/3/2024 | FY 2022 1/28/2023 | FY 2021 1/29/2022 | FY 2020 1/30/2021 | FY 2019 2/1/2020 | FY 2018 2/2/2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 107,705 | 104,780 | 106,566 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 76,144 | 75,511 | 76,502 | — | — | — | — | — | — | |
| Gross Profit | 31,561 | 29,269 | 30,064 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 22,872 | 21,535 | 21,969 | — | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | — | — | — | — | — | — | |
| Other Operating Expense | 2,666 | 2,617 | 2,529 | — | — | — | — | — | — | |
| Operating Income | 6,023 | 5,117 | 5,566 | — | — | — | — | — | — | |
| Interest Expense | 428 | 445 | 411 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 64 | 95 | 106 | — | — | — | — | — | — | |
| Net Income Before Taxes | 5,659 | 4,767 | 5,261 | — | — | — | — | — | — | |
| Income Taxes | 1,267 | 1,062 | 1,170 | — | — | — | — | — | — | |
| Consolidated Net Income | 4,392 | 3,705 | 4,091 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 4,392 | 3,705 | 4,091 | — | — | — | — | — | — | |
| Net Income | 4,392 | 3,705 | 4,091 | — | — | — | — | — | — | |
| EPS (Recurring) | 9.68 | 8.16 | 8.89 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 9.68 | 8.16 | 8.89 | — | — | — | — | — | — | |
| EPS (Diluted) | 9.63 | 8.13 | 8.86 | — | — | — | — | — | — | |
| EBITDA | 9,260 | 8,346 | 8,653 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 15.86 | 12.97 | 15.57 | — | — | — | — | — | — | |
| Price To Sales Ratio | 0.64 | 0.46 | 0.60 | — | — | — | — | — | — | |
| Gross Margin | 29.30 | 27.93 | 28.21 | — | — | — | — | — | — | |
| Operating Margin | 5.59 | 4.88 | 5.22 | — | — | — | — | — | — | |
| Net Margin | 4.08 | 3.54 | 3.84 | — | — | — | — | — | — | |
| Shares Outstanding | 454 | 454 | 460 | — | — | — | — | — | — | |
| Market Capitalization | 69,353 | 47,883 | 63,439 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Cornell Brian C | Executive Officer | Aug 25 '26 | Sale | 163.56 | 50,000 | 8,177,780 | 143,270 | Aug 27 |
| Kremer Melissa K | Executive Officer | Aug 24 '26 | Sale | 169.96 | 15,500 | 2,634,318 | 56,981 | Aug 26 |
| LIEGEL MATTHEW A | Chief Accounting Officer | Aug 21 '26 | Sale | 163.51 | 926 | 151,410 | 12,266 | Aug 24 |
| ROATH LISA R | Executive Officer | Jun 29 '26 | Sale | 138.07 | 7,000 | 966,490 | 35,465 | Jun 30 |
| SYLVESTER CARA A | Executive Officer | May 29 '26 | Sale | 125.89 | 10,000 | 1,258,905 | 45,930 | Jun 01 |
| Cornell Brian C | Executive Officer | May 27 '26 | Sale | 129.85 | 50,000 | 6,492,623 | 193,270 | May 28 |
| LIEGEL MATTHEW A | Chief Accounting Officer | Mar 17 '26 | Sale | 117.19 | 2,053 | 240,593 | 12,143 | Mar 19 |
| Cornell Brian C | Executive Officer | Mar 10 '26 | Sale | 121.76 | 50,000 | 6,088,025 | 196,453 | Mar 11 |
| LIEGEL MATTHEW A | Chief Accounting Officer | Jun 10 '25 | Sale | 100.90 | 2,044 | 206,245 | 11,064 | Jun 12 |
| Cornell Brian C | Executive Officer | May 28 '25 | Sale | 96.18 | 45,000 | 4,327,974 | 246,453 | May 30 |
| Cornell Brian C | Executive Officer | Mar 11 '25 | Sale | 113.37 | 45,000 | 5,101,488 | 258,843 | Mar 12 |
| LIEGEL MATTHEW A | Chief Accounting Officer | Mar 07 '25 | Sale | 113.52 | 287 | 32,580 | 7,173 | Mar 10 |
| Gomez Richard H. | Executive Officer | Sep 27 '24 | Sale | 157.17 | 6,348 | 997,715 | 123,551 | Sep 30 |
| LIEGEL MATTHEW A | Chief Accounting Officer | Aug 30 '24 | Sale | 153.13 | 1,000 | 153,130 | 7,276 | Sep 03 |
| Cornell Brian C | Executive Officer | Aug 27 '24 | Sale | 158.67 | 45,000 | 7,140,109 | 303,843 | Aug 28 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.